Diagnosis of Menopause Based on Lab Results
Menopause should be diagnosed primarily on clinical grounds—specifically age and menstrual history—without routine laboratory testing in most women. 1
Primary Diagnostic Approach
For Women with Intact Uterus (Standard Case)
- Diagnosis is clinical: 12 months of amenorrhea in a woman over age 40-45 1
- Laboratory testing is NOT recommended for routine diagnosis 1
- FSH, estradiol, inhibin B, and anti-Müllerian hormone measurements do not inform the diagnosis and will not influence management 1
Age-Based Criteria (When Labs Are Not Needed)
The Endocrine Society and NCCN guidelines provide clear age cutoffs 2, 3, 4, 2:
- Age ≥60 years: Menopause is presumed; no testing needed
- Age <60 years: Amenorrhea ≥12 months without chemotherapy, tamoxifen, or ovarian suppression = menopause
When Laboratory Testing IS Indicated
Laboratory testing should be reserved for specific clinical scenarios where menstrual history is inadequate 1:
Scenario 1: Post-Hysterectomy (Ovaries Intact)
When establishing menopausal status is necessary for patient management:
- Measure FSH and estradiol on multiple occasions (replicate measures) 1
- Postmenopausal ranges:
- FSH in postmenopausal range
- Estradiol <20 pg/mL 1
- Combine with presence of vasomotor symptoms for presumptive diagnosis 1
Scenario 2: Women on Hormonal Medications
For women age <60 taking tamoxifen or toremifene 2, 3, 4, 2:
- Require FSH AND estradiol in postmenopausal ranges
- Cannot rely on amenorrhea alone
Scenario 3: Post-Chemotherapy Amenorrhea
Critical caveat: Amenorrhea after chemotherapy is NOT a reliable indicator of menopausal status 2
- Ovarian function may still be intact or resume despite amenorrhea
- Serial FSH and/or estradiol measurements required if considering aromatase inhibitors 2
- Cannot assign menopausal status to women receiving LH-RH agonist/antagonist 2
Scenario 4: Women on Combined Hormonal Contraception
- FSH will be falsely suppressed on combined estrogen-progestin contraception 5
- Must discontinue hormonal contraception for at least 3 months before testing 5
- Macro-progestins with antigonadotropic action also suppress FSH 5
Laboratory Test Interpretation
FSH Thresholds
When testing is indicated 5, 2, 3, 4, 2:
- FSH >25 IU/L indicates POI/menopause in young women (outside pre-ovulation peak) 5
- FSH threshold has been lowered in recent years
- Autoimmune POI may have lower FSH (average 37 IU/L, range 26-64) than idiopathic POI 5
- Repeat testing in 1 month if initial FSH elevated and estradiol low 5
Estradiol Levels
- Estradiol <20 pg/mL supports postmenopausal status 1
- Low estradiol rules out pre-ovulation peak or estradiol-secreting cyst 5
- During pre-ovulation peak: estradiol typically 150-200 pg/mL per mature follicle 5
Common Pitfalls to Avoid
Single FSH measurement is unreliable 5, 1
- FSH fluctuates dramatically during perimenopause
- Women can have postmenopausal FSH levels then return to reproductive range 6
- Always use replicate measures when testing is indicated
Testing women on hormonal medications without washout period 5
- Results will be falsely reassuring
- Requires 3-month washout minimum
Relying on labs in women age ≥45 with typical menstrual changes 7, 8
- This represents inappropriate testing
- Clinical diagnosis based on age and menstrual history is sufficient
Using FSH to predict timing of menopause 1, 6
- FSH cannot indicate precisely when final menstrual period will occur
- 7% of regularly cycling women >45 years have postmenopausal FSH levels 6
Special Population: Premature Ovarian Insufficiency (Age <40)
For women <40 years with menstrual irregularity 5:
- Screen with FSH when amenorrhea or oligomenorrhea develops
- Include hCG, FSH, estradiol, and prolactin in initial workup
- Repeat FSH 1 month later if elevated with low estradiol 5
- FSH >25 IU/L (apart from pre-ovulation peak) indicates POI 5
The bottom line: Laboratory testing for menopause diagnosis should be the exception, not the rule, reserved only for situations where clinical criteria cannot establish the diagnosis.